• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Neuphoria Therapeutics released FY2026 Q1 earnings on November 14, 2025, EST: Actual Revenue USD 0 (Forecast USD 0), Actual EPS USD -4.4106 (Forecast USD -1.715)
04:00
Oct30
Neuphoria Therapeutics Inc. Holds 2025 Annual Shareholder Meeting and Voting
10:09
Oct24
Weston Nichols Buys Neuphoria Therapeutics Shares
18:05
Sep30
Neuphoria Therapeutics released FY2025 earnings on September 29 (EST), actual revenue USD 15.65 M (forecast USD 10.34 M), actual EPS USD -0.23 (forecast USD 1.49)
03:00
Neuphoria Therapeutics released FY2025 Q4 earnings on September 29 (EST), actual revenue USD -13.27K (forecast USD 0), actual EPS USD -4.6721 (forecast USD -2.835)
03:00
May27
Neuphoria Therapeutics to Present BNC210 PK/PD Analysis at ASCP Annual Meeting
20:12

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -9.907 M, EPS -4.4106

Sep29
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue -13.27 K, Net Income -8.884 M, EPS -4.6721

May20
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 15 M, Net Income 11.26 M, EPS 6.5499

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More